Literature DB >> 28745132

Joint incorporation of randomised and observational evidence in estimating treatment effects.

John Ferguson1, Alberto Alvarez-Iglesias1, John Newell1,2, John Hinde2, Martin O' Donnell1.   

Abstract

In evidence-based medicine, randomised trials are regarded as a gold standard in estimating relative treatment effects. Nevertheless, a potential gain in precision is forfeited by ignoring observational evidence. We describe a simple estimator that combines treatment estimates from randomised and observational data and investigate its properties by simulation. We show that a substantial gain in estimation accuracy, compared with the estimator based solely on the randomised trial, is possible when the observational evidence has low bias and standard error. In the contrasting scenario where the observational evidence is inaccurate, the estimator automatically discounts its contribution to the estimated treatment effect. Meta-analysis extensions, combining estimators from multiple observational studies and randomised trials, are also explored.

Keywords:  Observational study; meta-analysis; parametric bootstrap; randomised trial; root mean square error

Mesh:

Year:  2017        PMID: 28745132     DOI: 10.1177/0962280217720854

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  3 in total

1.  A multidisciplinary approach to online support for device research translation: regulatory change and clinical engagement.

Authors:  Anne-Marie Miller; Robert Behan; Ian Smith; Matthew Griffin; Fionnuala Keane; James Langan; Colm O'Rourke; Niall McAleenan; Abhay Pandit; Mark Watson
Journal:  Health Policy Technol       Date:  2020-10-15

2.  Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions.

Authors:  Michael Seo; Thomas Pa Debray; Yann Ruffieux; Sandro Gsteiger; Sylwia Bujkiewicz; Axel Finckh; Matthias Egger; Orestis Efthimiou
Journal:  Stat Methods Med Res       Date:  2022-04-26       Impact factor: 2.494

3.  EA3: A softmax algorithm for evidence appraisal aggregation.

Authors:  Francesco De Pretis; Jürgen Landes
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.